the Change of Cholesterol Efflux Capacity and Coronary Artery Disease in Real Clinical Practice
NCT03389529 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2018-03-16
Summary
The purpose of this study is to investigate the change of cholesterol efflux capacity in patients with coronary artery disease treated with secondary prevention drugs, and the correlation with the prognosis.
Conditions
- Coronary Artery Disease
- Cardiovascular Mortality
- Myocardial Infarction
- Stroke
Sponsors & Collaborators
-
First Affiliated Hospital of Jinan University
collaborator OTHER -
Lu'an Municipal Hospital
lead OTHER
Eligibility
- Min Age
- 30 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-04-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
More Related Trials
-
Study on the Registration of Coronary Heart Disease Patients Undergoing PCI
NCT02888652 ·Status: COMPLETED
-
Effect of Atorvastatin and Lifestyle Intervention on Progression of Pre-Clinical Atherosclerosis
NCT00723320 ·Status: UNKNOWN ·Phase: NA
-
Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome
NCT04087200 ·Status: RECRUITING
-
Inflammation and Coronary Endothelial Function
NCT02366091 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome
NCT06896708 ·Status: RECRUITING ·Phase: NA
-
Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis
NCT01106495 ·Status: COMPLETED ·Phase: NA
-
Colchicine Use for Primary Prevention of Coronary Artery Disease
NCT05175274 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
BIOchemical Urine Analysis of Adherence to Statins and Associated FACTorS in Coronary Artery Disease
NCT05814692 ·Status: UNKNOWN
-
Physical and Chemical Study of Atherosclerosis Mechanisms
NCT01700075 ·Status: COMPLETED ·Phase: PHASE4
-
Primary Prevention With Statin and Incidence of Recurrent MI and Cardiogenic Shock in Post-ACS Patients
NCT03596944 ·Status: COMPLETED
-
Progression of Sub-Clinical Atherosclerosis
NCT00241787 ·Status: COMPLETED
-
Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients
NCT03596931 ·Status: COMPLETED
-
Effect of Statins on the Radial Intima-media Thickness After Transradial Angioplasty
NCT00952770 ·Status: UNKNOWN ·Phase: PHASE4
-
Optimal LDL-C Target in High-risk Patients After PCI
NCT06821711 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
NCT01293097 ·Status: COMPLETED ·Phase: PHASE4
-
Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease
NCT02579499 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
NCT06520904 ·Status: RECRUITING ·Phase: PHASE4
-
Intestinal Microbiome and Extremes of Atherosclerosis
NCT03398889 ·Status: COMPLETED
-
Effects of Intensive Statin Treatment on Left Ventricular Function
NCT01936103 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin
NCT05500937 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease
NCT00917527 ·Status: UNKNOWN ·Phase: PHASE4
-
Relationship Between CETP Deficiency and Atherosclerosis in Patients With Hyperalphalipoproteinemia
NCT01916512 ·Status: UNKNOWN
-
Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease
NCT06425120 ·Status: RECRUITING ·Phase: PHASE4
-
Identification of CETP as a Marker of Atherosclerosis
NCT02081066 ·Status: COMPLETED ·Phase: NA
-
The Surem TRAF3IP2 Level and Atherosclerotic Plaque Development in Human
NCT05945394 ·Status: UNKNOWN